SIU Medicine Enrolling Patients for Alzheimer’s Disease Clinical Trial

April 20, 2021

The Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine is now enrolling patients with early-onset Alzheimer’s disease to help determine if an investigational drug is effective at treating this debilitating condition.

New Study looks at use of Riluzole to slow Alzheimer's progression

January 27, 2021

Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s disease (AD) (Clinical Trial #NCT01703117).

Dementia and Driving

October 30, 2020

According to the National Institute on Aging there are more than 41 million licensed drivers age 65 and older on the roads, up from 26 million 20 years ago.  As a person ages, changes in health-including problems with vision, hearing, and reflexes-may affect driving skills.  The risk of being inj

A hyperactive brain in Alzheimer’s disease

October 19, 2020

Neurons are the cells responsible for communicating important information to different areas of the brain.

COVID and Dementia Q&A Session

October 19, 2020

At SIU Medicine’s Center for Alzheimer’s Disease and Related Disorders, we are committed to the care for our patients and their families – especially during the pandemic.

SIU Medicine Group to Study COVID’s Potential Effects on Alzheimer’s

September 10, 2020

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify patients that are more susceptible to the disease’s cognitive and physical decline.

The Center for Alzheimer's Disease and Related Disorders at SIU Medicine received a grant from the King’s Daughters Organization for the fourth year in a row

September 4, 2020

The King’s Daughters Organization awarded the Center for Alzheimer’s Disease and Related Disorders (CADRD) a grant for $7,724 to support our Minds in Motion and Opening Minds Through Art (OMA) Beyond the Medical Center programs through 2021.   

Alzheimer's researchers note cause of Alzheimers to be multifaceted in new article

August 31, 2020

In August 2020, Erin Hascup PhD, Alzheimer's Center Director, and Kevin Hascup PhD, Assistant Professor published "Toward refining Alzheimer's disease into overlapping subgroups".